CIMT: Mechanisms of Efficacy in Cancer Immunotherapy | Mainz, Germany | Innate Pharma

Rheingoldhalle Congress Center

Rheinstraße 66 - 55116 Mainz - Germany

Date

Tue, 05/10/2016 - 09:00

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers